RNAZ

Latest SEC Filings & News for RNAZ

1 most recent filing and news item mentioning RNAZ. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/RNAZ/news?limit=20"

Pull RNAZ filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 3, 2026Positive

TransCode completes Phase 1a trial for TTX-MC138 with no dose-limiting toxicities

TransCode Therapeutics announced positive Phase 1a results for its lead candidate TTX-MC138, showing safety, tolerability, and disease stabilization in metastatic cancer patients across all dose cohorts. The company will advance to Phase 2a development targeting ctDNA-positive co

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.